Kimberly Johnson is associate professor at the Brown School. Her research focuses on identifying genetic and environmental factors for cancer, with a particular emphasis on pediatric cancer.
Johnson is the principal investigator of an international patient registry of individuals with the cancer syndrome Neurofibromatosis Type 1 (NF1) who incur a strongly increased risk for various tumor types, including pediatric brain tumors. She is conducting studies within this population that aim to understand genetic and environmental determinants of pediatric brain tumors. Johnson also collaborates with investigators at the Washington University McDonnell Genome Institute on discovery of genomic risk factors for cancer in both adults and children.
Johnson is a member of the Institute for Public Health, Siteman Cancer Center, and the American Association for Cancer Research, and she has a secondary appointment in the Department of Pediatrics at the Washington University School of Medicine.
As the coronavirus continues to spread across the nation, a number of false conclusions and rumors have spread with it. Three epidemiologists in public health at Washington University in St. Louis separate the truth from myth.
Racial and ethnic minority children and adolescents with cancer have a higher risk of death than non-Hispanic white children and adolescents, with evidence for larger disparities in survival for more treatable cancers, finds a new study from the Brown School at Washington University in St. Louis.
Childhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new study from the Brown School at Washington University in St. Louis.
Privately insured children and those with Medicaid at the time of a cancer diagnosis experience largely similar survival trends, with slight evidence for an increased risk of cancer death in children who were uninsured at diagnosis, finds a new study from the Brown School at Washington University in St. Louis.
Some children born with birth defects may be at increased risk for specific types of cancer, according to a new review from the Brown School and the School of Medicine at Washington University in St. Louis.
